Wednesday, 18 Oct 2017

You are here

CDC: Outbreak of Arthrocentesis Related Septic Arthritis Cases in New Jersey

It is estimated that the risk of septic arthritis following joint aspiration or injection is roughly 1:50,000.  While many injectable medications come with antimicrobial preservatives, the use of single-use medications, including pharmacy bulk packaged (PBP) products, may not include such preservatives and can become contaminated if handled inappropriately.

In March 2017, an outbreak of 41 cases of septic arthritis associated with intra-articular injections administered at an single outpatient practice occurred in New Jersey. A public health investigation identified multiple breaches of recommended infection prevention practices during the preparation and administration of PBP products. The intraarticular injections were done using fluoroscopic visualization. The CDC has reported the results of its investigation.

On March 6, 2017 the Monmouth County Regional Health Commission was notified by the NJ Dept. of Health that three patients were hospitalized for septic arthritis after receiving intra-articular injections for osteoarthritis of the knee.  The practice involved two staff physicians and two medical assistants. 

From this clinic and one provider, there were 250 patient visits for knee intra-articular injections between March 1 and March 6, that lead to 41 confirmed cases (16%) of septic arthritis. Symptoms were identifed from zero to 65 days after injection, with 92% having symptoms within 48 hours of the procedure. Thirty (73%) of the 41 patients required surgery.

Synovial fluid cultures were positive for in 37% of patients, with the following bacteria: Streptococcus mitis-oralis (10 patients), Abiotrophia defectiva (two), Staphylococcus aureus (two), Actinomyces odontolyticus (one), alpha-hemolytic Streptococcus (one), Eikenella corrodens (one), Haemophilus parainfluenzae (one), Neisseria oralis (one), Streptococcus gordonii (one), Streptococcus intermedius-milleri (one), Streptococcus sanguinis (one), and Veillonella (one); five patients had polymicrobial infections. Many of the cultured organisms are commonly found in oral flora. Staphylococcus aureus was isolated from the blood of two patients.

Numerous infection prevention errors were identified including: 

  • staff members did not have access to a handwashing sink
  • alcohol-based hand rub was not available in medication preparation or treatment areas
  • staff members were operating under the mistaken belief that PBP products could be used as multiple-dose containers outside of pharmacy conditions (e.g., use of a laminar flow hood, appropriate garbing, staff training, and environmental monitoring)
  • staff accessed the same 50 mL PBP container up to 50 times to prepare syringes for multiple patients (with the septum of the container cleaned with alcohol only before the initial draw)
  • staff members prepared injections in a separate room, away from the patient treatment area without the use of sterile conditions
  • injectable medications were drawn into syringes by medical assistants up to 4 days in advance of procedures
  • Injections were initiated using a needle and syringe filled with local anesthetic. After injecting the anesthetic, the physician removed the syringe, leaving the needle within the intra-articular space. A second syringe containing contrast material from the PBP container was then attached to the needle hub and used to facilitate fluoroscopic needle placement. This was followed by replacement with a third syringe containing a glucocorticoid or hyaluronic acid–based product
  • The physician did not wear a face mask during joint injection procedures and used nonsterile gloves to manipulate the needle hub during procedures

The practice was advised to immediately stop batch preparation of syringes and use of PBP products for multiple patients and to hire an infection preventionist to assess staff competency and ensure that hand hygiene, standard precautions, and safe injection practices were followed. No additional cases occurred after these measures were implemented.

Once infection prevention recommendations were implemented in the practice, no additional septic arthritis cases were reported. 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

Earlier news reports "named names" and outed the franchised establishment responsible for this travesty. Not hard to do a search and figure out which franchise was involved if you are unaware.
This unfortunate set of mistakes is nonetheless, a good lesson for what NOT TO DO.
Perhaps I'm naive but the thing that made my eyes pop was one provider doing *250* knee injections in a 5 day period (which included a weekend!)...

More Like This

Increased Deaths in RA, Despite Decreasing Mortality Rates

Data from the Swedish Rheumatology Quality (SRQ) Register studied death rates in patients with rheumatoid arthritis (RA) between 1997 and 2014.  Holmqvist and colleagues studied 17,512 RA and 78,847 matched controls from the general population, until their death.

For both the RA patients and general population, they noted steady decrease in mortality rates over time.

Mortality with Interstitial Lung Disease in Rheumatoid Arthritis

Annals of Rheumatic Disease has published a Danish population based study demonstrating the high mortality rates seen with interstitial lung disease (ILD).

Between the years 2004 and 2016, researchers identified 679 RA patients with RA-ILD and matched these (age, gender) against 11 722 RA patients without ILD.

Sarcoid and Rheumatoid Arthritis Risk Increased by Silica Exposure

A Swedish study has shown that occupational silica exposure increases the incidence rates of sarcoidosis and rheumatoid arthritis (RA) in those exposed workers in Swedish iron foundries.

Researchers studied personnel records from 10 iron foundries to identify workers who may be at risk.  They examined 2187 silica-exposed male workers exposed for at least 1 year for a total of 23,807 person-years at risk.

Rheumatoid Arthritis Augments Cardiovascular Risk

A large multi-center study of cardiovascular (CV) risk factors in rheumatoid arthritis (RA) has shown, after nearly 6 years follow-up, more CV events in males than females (21% vs. 11%, respectively) and that RA itself accounts for 30% of the attributable CV risk.

Do Rheumatologists Use ACR/EULAR Guidance on Rheumatoid Arthritis? “Live Vote” Results

The June 2017 RheumNow “Live Vote” surveyed US and non-US rheumatologists and patients about how they diagnose and treat rheumatoid arthritis (RA) and whether they rely on newer diagnostic criteria and management guidelines propagated by the American College of Rheumatology (ACR).